SANGAMO BIOSCIENCES
SANGAMO BIOSCIENCES operates in Diversified Metals & Mining.
SANGAMO BIOSCIENCES (GBY) - Net Assets
Latest net assets as of June 2024: €23.69 Million EUR
Based on the latest financial reports, SANGAMO BIOSCIENCES (GBY) has net assets worth €23.69 Million EUR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€93.01 Million) and total liabilities (€69.32 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €23.69 Million |
| % of Total Assets | 25.47% |
| Annual Growth Rate | -6.85% |
| 5-Year Change | -80.85% |
| 10-Year Change | N/A |
| Growth Volatility | 49.27 |
SANGAMO BIOSCIENCES - Net Assets Trend (2016–2023)
This chart illustrates how SANGAMO BIOSCIENCES's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SANGAMO BIOSCIENCES (2016–2023)
The table below shows the annual net assets of SANGAMO BIOSCIENCES from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €82.89 Million | -71.90% |
| 2022-12-31 | €294.96 Million | -21.42% |
| 2021-12-31 | €375.34 Million | -24.53% |
| 2020-12-31 | €497.37 Million | +14.93% |
| 2019-12-31 | €432.74 Million | +17.83% |
| 2018-12-31 | €367.26 Million | +95.45% |
| 2017-12-31 | €187.90 Million | +37.96% |
| 2016-12-31 | €136.19 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to SANGAMO BIOSCIENCES's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 96546500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €1.49 Billion | 1796.74% |
| Total Equity | €82.89 Million | 100.00% |
SANGAMO BIOSCIENCES Competitors by Market Cap
The table below lists competitors of SANGAMO BIOSCIENCES ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CMC Investment JSC
VN:CMC
|
$3.46K |
|
LIVESTOCK FEED LTD (ORDINARY)
SEM:LFL-O
|
$3.46K |
|
Ayfie International AS
OL:AIX
|
$3.47K |
|
ALLTAINER AB O.N.
F:70H
|
$3.47K |
|
BK GROUP PLC
XNAI:BKG
|
$3.46K |
|
PROPHECY PLATINUM
BE:P94P
|
$3.46K |
|
Traack Technologies Inc
PINK:TRAA
|
$3.46K |
|
Huaxia Fund Management Co.Ltd. - China Resources Youchao REIT
SHG:508077
|
$3.46K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SANGAMO BIOSCIENCES's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 294,958,000 to 82,887,000, a change of -212,071,000 (-71.9%).
- Net loss of 257,831,000 reduced equity.
- New share issuances of 15,106,000 increased equity.
- Other factors increased equity by 30,654,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-257.83 Million | -311.06% |
| Share Issuances | €15.11 Million | +18.22% |
| Other Changes | €30.65 Million | +36.98% |
| Total Change | €- | -71.90% |
Book Value vs Market Value Analysis
This analysis compares SANGAMO BIOSCIENCES's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.76x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.16x to 0.76x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €2.20 | €0.35 | x |
| 2018-12-31 | €3.59 | €0.35 | x |
| 2019-12-31 | €3.73 | €0.35 | x |
| 2020-12-31 | €3.51 | €0.35 | x |
| 2021-12-31 | €2.57 | €0.35 | x |
| 2022-12-31 | €1.77 | €0.35 | x |
| 2023-12-31 | €0.47 | €0.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SANGAMO BIOSCIENCES utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -311.06%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -146.30%
- • Asset Turnover: 1.07x
- • Equity Multiplier: 1.99x
- Recent ROE (-311.06%) is below the historical average (-71.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -52.61% | -369.58% | 0.12x | 1.16x | €-85.28 Million |
| 2017 | -29.04% | -149.23% | 0.13x | 1.53x | €-73.36 Million |
| 2018 | -18.64% | -80.91% | 0.14x | 1.61x | €-104.99 Million |
| 2019 | -22.01% | -92.93% | 0.16x | 1.47x | €-138.44 Million |
| 2020 | -24.28% | -102.37% | 0.13x | 1.88x | €-170.82 Million |
| 2021 | -47.50% | -161.05% | 0.15x | 1.92x | €-215.82 Million |
| 2022 | -65.19% | -172.76% | 0.20x | 1.91x | €-221.77 Million |
| 2023 | -311.06% | -146.30% | 1.07x | 1.99x | €-266.12 Million |
Industry Comparison
This section compares SANGAMO BIOSCIENCES's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SANGAMO BIOSCIENCES (GBY) | €23.69 Million | -52.61% | 2.93x | $3.46K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |